Susannah Gray

Ms. Susannah Gray is an Independent Director at AnaptysBio, Inc., a Chairman at Theravance Biopharma, Inc., an Independent Director at Maravai Lifesciences Holdings, Inc. and an Independent Director at 4D Molecular Therapeutics, Inc. She is on the Board of Directors at AnaptysBio, Inc., Morphic Therapeutic, Inc., Maravai Life Sciences, Inc., Maravai Lifesciences Holdings, Inc., 4D Molecular Therapeutics, Inc., Biosplice LLC, Biosplice Therapeutics, Inc., Colby College Museum of Art, StreetSquash, Susan G.
Komen Foundation, The German Marshall Fund of United States and Wesleyan University.
Ms. Gray was previously employed as an Independent Director by Apria, Inc., an Independent Director by Morphic Holding, Inc., an Executive Vice President-Finance & Strategy by Royalty Pharma Management LLC, an Executive Vice President-Finance & Strategy by RP Management LLC, an Analyst by CIBC World Markets Corp.
(Old), and a Managing Director by Merrill Lynch & Co., Inc. /Old/.
She also served on the board at Susan G.
Komen for the Cure.
She received her undergraduate degree from Wesleyan University and an MBA from Columbia Business School.